RobertS.Copeland-HalperinMDFACC

Cardiology • New York, NY

Nuclear Cardiology, Non-Invasive Cardiology, Vascular Medicine

Director of Cardio-Oncology, Northwell Health System

Join to view full profile

Dr. Copeland-Halperin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Copeland-Halperin's full profile

Already have an account?

Office
7 Seventh Avenue
New York, NY 10011
Phone+1 718-470-7330

Summary

Fellowship trained Cardio-Oncologist specializing the Cardiovascular Care of Patients with Cancer.
Member ACC Cardio-Oncology Leadership Council

Education & Training

Memorial Sloan Kettering Cancer CenterFellow, Cardio-Oncology, Cardio-Oncology, 2019 - 2020
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2016 - 2019
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2013 - 2016
Icahn School of Medicine at Mount SinaiClass of 2013
Hamilton CollegeB.A., Psychology, Psi Chi Honor Society, 2001 - 2005

Certifications & Licensure

FL State Medical License 2024 - Present
NY State Medical License 2017 - 2026
PA State Medical License 2018 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
Certification Board of Nuclear CardiologyNuclear Cardiology

Awards, Honors, & Recognition

Fellow of the American College of Cardiology American College of Cardiology, 2020
Alpha Omega Alpha Icahn School of Medicine at Mount Sinai, 2014
Gold Humanism Honor Society Icahn School of Medicine at Mount Sinai, 2013

Clinical Trials

Abatacept in Immune Checkpoint Inhibitor Myocarditis Start of enrollment: 2022 Jun 22
RECRUITING
PHASE3
AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS Start of enrollment: 2022 Oct 04
ACTIVE_NOT_RECRUITING
PHASE2
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors Start of enrollment: 2023 Jan 01
Recruiting
Not Applicable
Global Cardio Oncology Registry Start of enrollment: 2022 Jul 01
Recruiting
Join now to see all

Publications & Presentations

PubMed

Non-Bacterial Thrombotic Endocarditis in Lung Cancer: A Systematic Review.
Maikel Kamel, Fahad Hussain, Christian Leung, Awais Paracha, Pranav Sathe
Current Cardiology Reviews. 2025-02-11
New-Onset Graves' Disease Presenting As Thyro-Pericarditis.
Ji-Cheng Hsieh, Spencer Weintraub, Karim Diab, Ally W Wang, Robert Copeland-Halperin
Cureus. 2024-07-01
Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology.
Rose Mary Attieh, Belen Nunez, Robert S Copeland-Halperin, Kenar D Jhaveri
Cardiorenal Medicine. 2024-01-01

Books/Book Chapters

Atlas of Imaging in Cardio-Oncology
Chapter: Cardio-Oncology in the COVID-19 Era
Page 291 - 306Stephanie Feldman, Kristine Jang, Dylana Smith, Robert S. Copeland-HalperinEditors: Jennifer Liu and Richard Steingart.Springer Nature2021

Abstracts/Posters

INCIDENCE OF BRUTON TYROSINE KINASE INHIBITOR ASSOCIATED ARRHYTHMIAS: A PROSPECTIVE ANALYSIS USING CONTINUOUS INSERTABLE CARDIAC MONITORS
Jason Ng, Adrian Chen, Maikel Kamel, Stephanie Benedictus, Michelle Jaeger, Joanna Rhodes, Haisam Ismail, Robert S. Copeland-Halperin, American College of Cardiology, Chicago, IL, 3/30/2025
DASATINIB INDUCED PULMONARY ARTERIAL HYPERTENSION
Jennifer Drummond, Jason Ng, and Robert S. Copeland-Halperin, American College of Cardiology, Chicago, IL, 3/2025
THE GLOBAL CARDIO-ONCOLOGY REGISTRY (G-COR) US PILOT STUDY: EARLY COHORT BREAST CANCER PATIENTS DEMOGRAPHICS AND EXERCISE HABITS
Diego B. Sadler, Vijay U. Rao, Rohit Moudgil, Anna D. Narezkina, Brenton Scott Bauer, Vinisha Garg, Brijesh Patel, Nausheen Akhter, Mini K. Das, Anita Deswal, Aarti As..., American College of Cardiology, Atlanta, GA, 4/2024
5-FLUOROURACIL INDUCED VASOSPASM AND ACUTE HEART FAILURE
Zohair Ali, Robert S. Copeland-Halperin, and Bani Mekisha Azari, American College of Cardiology, Atlanta, GA, 4/2024
DIFFUSE LARGE B-CELL LYMPHOMA WITH CARDIAC INVOLVEMENT MASQUERADING AS INFILTRATIVE CARDIOMYOPATHY
Karsh Gaurav, Sirish Vullaganti, and Robert S. Copeland-Halperin, American College of Cardiology 2024, Atlanta, GA, 4/2024
ABATACEPT AND RUXOLITINIB FOR PEMBROLIZUMAB INDUCED MYOCARDITIS WITH CARDIOGENIC SHOCK REFRACTORY TO HIGH DOSE STEROIDS
Mordechai Grabie, Andrew M. Cyr, and Robert S. Copeland-Halperin, American College of Cardiology 2024, Atlanta, GA, 4/2024
CONSTRICTIVE PERICARDITIS MASQUERADING AS CIRRHOSIS
Gregory Marecki, Thomas F. Cunningham, Robert S. Copeland-Halperin, and Hillary Johnston-Cox, American College of Cardiology, New Orleans, LA, 3/2023
Severe Recurrent Pulmonary Arterial Hypertension from Bosutinib Following Dasatinib Induced Pulmonary Toxicity
Robert S. Copeland-Halperin, M.D. &amp; Anthony F. Yu, M.D., ACC's Advancing the Care of the Cardio-Oncology Patient, Washington, DC, 2/2020
Autoimmune Myocarditis With AV Block
Robert S Copeland-Halperin, MD, FACC; Martin E. Goldman, MD, FACC; Gagan D. Sahni, MD, FACC, ACC: Advancing the Care of The Cardio-Oncology Patient, Washington, DC, 5/29/2018
Join now to see all

Authored Content

ACC Expert Review: Adverse Effects of Bruton's Tyrosine Kinase Inhibitors: What All Cardiologist's Should KnowAugust 2023

Grant Support

Continuous EKG Monitoring During Initiation of Immune-Checkpoint Inhibitors to Identify Patients at Risk for MyocarditisMedtronic Inc2025–Present
Implanted Loop Recorders in Patients Initiating BTK inhibitorsMedtronic Inc2021–Present